drugset / Trial / NCT00456820

Wellbutrin XL Effects on SSRIs Induced Changes

NCT00456820

Phase 4 Completed 15 enrolled Indiana University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out differences in activation of mood regulating areas of the brain in response to negative and positive pictures, before and after 6 weeks of additional Wellbutrin XL treatment. Participants should have been treated for depression with an SSRI medication (e.g., Prozac, Zoloft, Paxil, Celexa or Lexapro) and have decreased depression symptoms but also be experiencing side effects of medications such as sexual side effects and feelings of apathy (indifference, lack of interest) and lack of full emotional response. We will first take a brain scan to measure activity in different parts of the brain, while subjects are seeing pictures, using Magnetic Resonance Imaging (MRI) scan. Then we will add Wellbutrin XL - another well-known antidepressant that acts by increasing the chemical dopamine in the brain, to subjects' treatment. Wellbutrin addition is useful in decreasing the sexual side effects of SSRIs. After treatment with Wellbutrin XL for 6 weeks subjects will have a second MRI scan with picture rating.

Timeline

Start
2004-07
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg Oral
Subject Bupropion Small molecule 450 mg Oral